Breaks Categories: News

ThursdayMay 14, 2026 9:36 am

NetworkNewsBreaks – BOXABL, FG Merger II Advance Proposed Business Combination Following SEC Effectiveness of Form S-4 

BOXABL and FG Merger II Corp. (NASDAQ: FGMC) announced that the U.S. Securities and Exchange Commission has declared effective the companies’ joint registration statement on Form S-4 related to their proposed business combination, marking a significant milestone in BOXABL’s path to becoming a publicly traded company. Shareholder meetings to approve the transaction are scheduled for June 9, 2026, with closing expected shortly thereafter, subject to customary conditions, after which the combined company is expected to trade on Nasdaq under the ticker symbol BXBL. To view the full press release, visit https://nnw.fm/vSixg About BOXABL BOXABL is transforming the housing market with its modular building systems…

Continue Reading

ThursdayMay 14, 2026 9:10 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart attack detection and ambulatory ECG patch initiatives, and an April public offering that raised $11.5 million in gross proceeds. The company reported a first-quarter net loss of $4.7 million, improved from $5.5 million in the prior-year period, with research and development expenses declining year over year as HeartBeam continued advancing commercialization of its FDA-cleared cardiac monitoring platform and related growth initiatives. To view the full press release, visit https://nnw.fm/guMCF About HeartBeam, Inc. HeartBeam,…

Continue Reading

ThursdayMay 14, 2026 9:00 am

NetworkNewsBreaks – Nevada Organic Phosphate Inc. CSE: NOP; OTCQB: NOPFF) Announces Non-Brokered Private Placement of Up to $2 Million

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based leader in organic sedimentary phosphate exploration, announced plans to complete a non-brokered private placement of up to 11.1 million units at $0.18 per unit for gross proceeds of up to $2 million. Proceeds are expected to fund the phase two drill program at the company’s Murdock Property and general working capital. To view the full press release, visit https://nnw.fm/bueMz Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) NOP is a junior exploration company with…

Continue Reading

WednesdayMay 13, 2026 11:55 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Permanent Ukraine Operations to Accelerate Overwatch Adoption

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced plans to establish permanent operations in Ukraine through a wholly owned subsidiary to accelerate adoption of its Overwatch autonomous mission software across the country’s defense drone market. The expansion includes building an in-country commercial and technical team, opening a physical office, and appointing Greg Daly as chief strategy and mission integration officer to lead execution, as the company works to convert growing engagement with Ukrainian drone manufacturers and operators into recurring software sales while expanding…

Continue Reading

WednesdayMay 13, 2026 11:51 am

NetworkNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Advances São Sepé Rare Earth Project With Drill Program Underway 

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.  Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) provided an update on its São Sepé rare earth project in Brazil, where historical surface sampling identified three priority exploration targets prospective for ionic adsorption clay-hosted rare earth mineralization. The company has commenced an approximately 500-meter auger drill program, expected to run four to six weeks, to follow up on elevated rare earth oxide values and test the lateral continuity of potential mineralization across the Sara, Erica and Maya target areas. To view the full press release, visit https://nnw.fm/hX5Fx About Canamera Energy Metals Corp. Canamera Energy Metals Corp. is a rare earth and critical metals exploration company…

Continue Reading

WednesdayMay 13, 2026 11:40 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Software-Driven Drone Autonomy 

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising.  SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) was featured in AINewsWire editorial coverage examining the accelerating shift toward software-defined autonomous warfare, with the company highlighted for its Overwatch platform designed to provide GPS-denied navigation and precision targeting for low-cost drones operating in contested environments. The editorial emphasizes that while inexpensive drone hardware has become widely available and increasingly central to modern conflict, particularly in active war zones, the software intelligence required for autonomous operation under electronic warfare conditions remains a critical gap SPARC AI is seeking to address. The coverage also positions SPARC AI alongside other defense and…

Continue Reading

WednesdayMay 13, 2026 11:31 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Announces First Patient Dosed in Phase 1b Trial of Sapu003 

Oncotelic Therapeutics (OTCQB: OTLC), alongside Sapu Nano, announced that the first patient has been dosed in the Phase 1b clinical trial evaluating Sapu003, an investigational intravenous Deciparticle(TM) formulation of everolimus for patients with advanced mTOR-sensitive solid tumors. The open-label, dose-escalation study is designed to assess safety, tolerability, pharmacokinetics and preliminary anti-tumor activity across patient cohorts including HR-positive/HER2-negative breast cancer and multiple additional tumor types, with Sapu003 developed as a weekly IV formulation intended to address limitations associated with oral everolimus delivery, including variable absorption and dose-limiting toxicity. To view the full press release, visit https://nnw.fm/XXnpF About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development…

Continue Reading

WednesdayMay 13, 2026 9:35 am

NetworkNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) was featured in BioMedWire editorial coverage examining the rapid growth of the GLP-1 market, with the company highlighted for its subsidiary GlucaPharm Inc. and its development of GEP-44, a patented triple agonist peptide licensed from Syracuse University. The editorial notes that GEP-44 is designed to target GLP-1 and peptide YY receptors Y1 and Y2, positioning SureNano as an emerging microcap participant seeking to address limitations of first-generation GLP-1 therapies, including efficacy, tolerability and delivery flexibility. The coverage also…

Continue Reading

WednesdayMay 13, 2026 9:20 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery

Oncotelic Therapeutics (OTCQB: OTLC) was featured in BioMedWire editorial coverage examining the growing urgency around effective central nervous system drug delivery, with the company highlighted for its proprietary intranasal nose-to-brain delivery platform designed to bypass the blood-brain barrier and deliver therapeutics directly to the brain. The editorial points to rising global Alzheimer’s cases and increased biodefense focus as major catalysts driving demand for faster, more targeted CNS delivery technologies, positioning Oncotelic’s platform-based approach as part of a broader shift toward delivery innovation as a critical determinant of therapeutic success. The coverage also places Oncotelic alongside major biopharma and advanced therapeutics…

Continue Reading

WednesdayMay 13, 2026 9:10 am

NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in BioMedWire editorial coverage highlighting the growing demand for real-time, noninvasive impairment detection technologies, with the company positioned as a differentiated player leveraging artificial intelligence and voice analysis to identify intoxication from brief speech recordings. The editorial underscores the limitations of conventional detection tools such as breathalyzers, blood draws and urine testing, noting MindBio’s focus on scalable, real-time assessment across multiple substances for potential applications in workplace safety, law enforcement, healthcare and public health.…

Continue Reading